PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease
Areum Jo(Sungkyunkwan University), Joo‐Ho Shin(Chonnam National University), Deborah A. Swing(National Cancer Institute), Lino Tessarollo(National Institutes of Health), Stewart Neifert(Johns Hopkins University), Ted M. Dawson(Johns Hopkins University), Sung-Ung Kang(Johns Hopkins University), Valina L. Dawson(Johns Hopkins University), Han Seok Ko(Johns Hopkins University), Xiaobo Mao(Johns Hopkins University), Sangwoo Ham(Samsung (South Korea)), Haisong Jiang(Kyushu University), Sheila K. Pirooznia(Johns Hopkins University), Shaida A. Andrabi(Johns Hopkins University), Sun Ha Paek(Seoul National University), Chan Hyun Na(Johns Hopkins University), Jin Whan Cho(Samsung Medical Center), Shih-Ching Chou(Johns Hopkins University), Senthilkumar S. Karuppagounder(Johns Hopkins University), Tae‐In Kam(Johns Hopkins University), George K. E. Umanah(Johns Hopkins University), Manoj Kumar(Indian Institute of Toxicology Research), Hanna Kim(Sungkyunkwan University), Hye-In Kim(Samsung (South Korea)), Ji-Yeong Lee(Sungkyunkwan University), Hyojung Kim(Samsung (South Korea)), Hyejin Park(Institute for Basic Science), Byoung Dae Lee(Kyung Hee University), Yunjong Lee(Sungkyunkwan University), Sungtaek Oh(Agricultural Research Service), Hojin Kang(Samsung (South Korea)), Rin Khang(Samsung (South Korea)), Chi‐Hu Park(Sungkyunkwan University), Ho Chul Kang(Johns Hopkins University)
Cited by 64
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
Phytochemicals as antibiotic alternatives to promote growth and enhance host health
|Veterinary Research|2018|501
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
|Molecular Neurodegeneration|2020|484